Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...
Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing ...
Despite the rapid invention and widespread use of artificial intelligence (AI), the federal government is just beginning to shape the ...
TipRanks on MSN
Celcuity submits gedatolisib new drug application to the FDA
Celcuity (CELC) announced the completion of the submission of its new drug application to the FDA for gedatolisib in hormone receptor positive, ...
FDA grants Fast Track designation to DPTX3186, Dewpoint’s first in class condensate modulator for gastric cancerDesignation provides increased ...
The Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2025 ...
Microcontroller units (MCUs) are single-chip computers optimized for performing embedded computing tasks like controlling a ...
Medical Device Network on MSN
FDA and EU clear Zap Surgical’s radiosurgery planning system
Achieved using radiosurgery systems such as Zap’s ZAP-X, Axon is specifically designed for planning cranial stereotactic ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app.
Detailed price information for Tandem Diabetes Care (TNDM-Q) from The Globe and Mail including charting and trades.
The "FDA Regulatory Compliance for Drug and Biotech Products (Nov 12th - Nov 13th, 2025)" training has been added to ResearchAndMarkets.com's offering. Regulatory Compliance is the level of activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback